Friday, March 29, 2024
HomeIndustriesHealthcare

Healthcare

Synaptogenix Moves Forward with Clinical Development Plans for Bryostatin-1 as a Treatment for Multiple Sclerosis

Synaptogenix, Inc., a clinical-stage biopharmaceutical company developing regenerative therapeutics for neurodegenerative disorders, announced plans to develop Bryostatin-1 for the treatment of multiple sclerosis ("MS"),...

Jupiter Neurosciences, Inc. Announces Completion of Phase I Safety Trial with Enhanced Resveratrol Product, JOTROL

Jupiter Neurosciences, Inc.,  announced the completion of its Phase I clinical trial with its proprietary JOTROL™, an enhanced formulation of resveratrol with increased bioavailability....

Jacobio JAB-21822 in Combination with Cetuximab Completes First Dose of Colorectal Cancer Patient in China

Jacobio Pharmaceuticals announced that its KRAS G12C inhibitor JAB-21822 completed the first patient dosing in combination therapy with Cetuximab at Peking University Cancer Hospital...

AMRA Medical’s MRI-Based Muscle Assessment Technology Approved for Clinical Use in US and Canada

AMRA Medical, a ground-breaking digital health company and global leader in body composition analysis offering medical device and medical research services, announced that AMRA...

Fluence Analytics Announces New Biopharma Analysis Product

Fluence Analytics, a venture-backed global leader in continuous polymer reaction monitoring and control, announced a further expansion of its biopharmaceutical product line with the...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics